| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 222 | 203 | 130 | 285 | | Cost of Revenue | 80 | 107 | 61 | 11 | | | Gross Profit | 142 | 96 | 69 | 274 | | | Operating Expenses | | Research Development | 458 | 415 | 312 | 454 | | Selling General and Administrative | 1,405 | 1,376 | 1,323 | 2,044 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,721) | (1,695) | (1,566) | (2,224) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9 | 1 | 20 | 5 | | Earnings Before Interest And Taxes | (1,711) | (1,694) | (1,546) | (2,220) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,711) | (1,694) | (1,546) | (2,220) | | Income Tax Expense |
-
| 2 |
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,711) | (1,697) | (1,546) | (2,220) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,711) | (1,697) | (1,546) | (2,220) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,711) | ($1,697) | ($1,546) | ($2,220) |
|
0.03% Nasdaq 
0.42%
Income Statement
